Siemens (NYSE:SI) Healthineers said today it agreed to acquire Alere‘s (NYSE:ALR) Epocal point-of-care blood diagnostic business as Alere looks to clear regulatory hurdles in its pending acquisition by Abbott (NYSE:ABT). Financial details of the acquisition were not disclosed, but the companies said that the acquisition is subject to the completion of Abbott’s purchase of Alere. Alere said the […]
Tissue Regenix (LON:TRX) shares came under pressure today after the regenerative medicine company said it paid $30 million (£23 million) to acquire CellRight Technologies and its line of spine surgery and orthopedics products. Leeds, U.K.-based Tissue Regenix said it funded the deal with a $52 million (£40 million) flotation of 400 million shares. CellRight is based in San Antonio, […]
The Federal Trade Commission approved Baxter‘s (NYSE:BAX) $625 million acquisition of Claris Lifesciences‘ (BOM:533288) injectable drug biz, but mandated that the companies divest two drugs products – an antifungal agent, fluconazole, and intravenous milrinone. The FTC filed a complaint saying that the original deal would likely reduce competition in the U.S. for fluconazole since Baxter and […]
ConvaTec (LON:CTEC) said today it agreed to acquire US-based distributor Woodbury Holdings from MTS Health Investors for approximately $120.5 million. Floral Park, N.Y.-based Woodbury Holdings is an independent national distributor of incontinence and catheter products, as well as nutritional, enteral feeding and vascular compressions supplies, Convatec said, providing direct-to-home delivery across the US. With the acquisition, […]
Akorn Inc. (NSDQ:AKRX) shareholders voted yesterday to approve its $4.75 billion merger deal with German healthcare company Fresenius (ETR:FRE). Fresenius’ Kabi division announced in April that it inked a deal to acquire the generic drugmaker, bringing with it a portfolio of ophthalmic drugs, ear drops, nasal sprays, respiratory drugs and medical creams. Get the full story at our sister site, Drug Delivery Business News.
Cardinal Health (NYSE:CAH) is reportedly shopping its Chinese drug distribution business, drawing keen interest from state-backed pharmaceutical firms in a deal that could be worth as much as $1.5 billion. Citing “sources familiar with the matter,” Reuters reported that Shanghai Pharmaceutical, China Resources Pharmaceutical Group and Sinopharm Group are among the potential bidders for Cardinal Health China, […]
GW Plastics said today that it has bought Avenue Mould Solutions, a precision mold building, machining, and injection molding company based in Sligo, Ireland. Get the full story on our sister site, Medical Design & Outsourcing.
Royal Philips (NYSE:PHG) said yesterday that it agreed to acquire TomTec Imaging Systems and its intelligent image analysis software for an undisclosed amount. Munich-based TomTec makes multi-modality and vendor-neutral diagnostic and analysis applications for cardiology, radiology and OB/GYN, the Dutch healthcare conglomerate said. Founded in 1990, TomTec employs more than 100 workers in the U.S., Europe and […]
(Reuters) — Long-suffering Novartis (NYSE:NVS) unit Alcon‘s sales growth accelerated in the second quarter, boosting options for the business including a possible disposal, CEO Joe Jimenez said today. The eye care subsidiary’s sales rose 1% to $1.5 billion, including intraocular lens revenues, which grew for the first time in the second quarter since 2014. Spending continued […]
Syneron Candela said today that its approximately $400 million sale to private equity fund Apax Partners closed today, and that it is now functioning as a privately held company under Apax. Apax Partners paid $11 per share in cash for Syneron, with shares ceasing trading on the Nasdaq Stock Market this morning and the company delisting from the […]
Abbott (NYSE:ABT) said today that it launched the tender offer for its $5.3 billion acquisition of diagnostics giant Alere (NYSE:ALR). The $402-per-share tender offer is slated to expire at midnight on August 11, Abbott said. The merger was amended in April, when Abbott agreed to pay $5.3 billion for Alere rather than the original price of $5.8 billion. Get […]